copy of dr. kahl on patient preference in treatment selection for cll
Published 5 years ago • 26 plays • Length 0:15Download video MP4
Download video MP3
Similar videos
-
0:54
dr. kahl on patient preference in treatment selection for cll
-
2:03
dr. kahl on considerations for treatment strategies in cll
-
1:53
dr. kahl on frontline btk inhibitor selection in cll
-
1:35
dr. kahl on frontline therapy selection in cll
-
1:43
dr. kahl on ibrutinib in cll
-
4:17
how to approach r/r cll
-
7:40
managing follicular lymphoma
-
3:08
laddl covid 19 testing laboratory
-
2:02
dr. kahl on promising research in chronic lymphocytic leukemia
-
1:33
dr. kahl on the utility of tafasitamab/lenalidomide in dlbcl
-
0:57
dr. kahl discusses unmet needs in mcl
-
0:20
copy of dr. hill on recent advances in treatment of cll
-
1:01
dr. kahl on btk inhibitor time-definite trials in cll
-
2:03
comprehensive geriatric assessments can aid in selecting treatment for elderly patients with cll
-
6:45
essential lab tests for cll patients
-
9:03
up-front ibrutinib versus fcr for patients with cll
-
1:07
dr. kahl discusses the potential of frontline ibrutinib in mcl
-
1:54
selecting therapy for patients with cll
-
1:05
dr. kahl on the current treatment landscape in relapsed/refractory inhl
-
1:25
dr. kahl on remaining challenges in indolent non-hodgkin lymphoma
-
2:03
dr. hill on recent advances in treatment of cll
-
0:14
copy of dr. talley on the captivate trial in cll